Participating in the From Lab to Market Challenge hosted by the GreenChem Invention Factory was an important milestone for Ecolation. We were selected as one of twelve startups in the northern cohort and ultimately finished in fourth place.
On paper that may sound like a respectable but not exceptional result. In context it meant more. Ecolation was the only TRL II startup in the group while most participating ventures were already operating at TRL III to VI. We entered as the earliest-stage company in the room and competed against teams with more mature technologies, developed prototypes and significantly more technical progress.
External validation at a very early stage
At TRL II a company is not presenting a finished product, a validated prototype or an industrial process ready for deployment. It is presenting something more fragile and more difficult to judge: a technically grounded concept, a credible path forward and a team capable of turning scientific logic into something commercially relevant.
Being selected at this stage was already a signal. Finishing fourth among significantly more mature ventures reinforced that signal. It suggested that clear problem framing, team quality, market understanding and the ability to communicate a science-based concept can stand out long before a product is market-ready.
Why early-stage deeptech is difficult to pitch
Very early-stage deeptech lives in an awkward middle ground. It is too early to point to commercial traction or a fully validated product and too technical to be understood through startup language alone.
The pitch must communicate ambition without exaggeration, scientific depth without becoming inaccessible and commercial relevance without pretending the technology is further along than it is.
At higher TRLs a larger share of the story can be carried by prototypes, pilot projects, test data or operational proof points. At TRL II much more of the case rests on the logic of the concept, the credibility of the path forward, the quality of the team and the seriousness with which market and execution questions are addressed.
Why team quality matters so much
At very early stages investors, partners and judges are not backing a finished technology. They are backing a team’s ability to move a technology through uncertainty. A company cannot yet point to industrial rollout. It can show whether it combines the right capabilities to get there.
At Ecolation that means combining material-science expertise, financial and operational experience, strategic capital and business-driven venture development. That combination is essential when bridging the gap between a promising concept and a future market-ready solution.
What the experience taught us
The challenge was not only a competition. It was a useful reality check. It reminded us that early-stage deeptech must constantly balance three things:
- Scientific credibility
- Commercial logic
- Communication clarity
If one is missing the overall story weakens quickly. Early ventures are judged not only on what they have built but also on whether others can realistically imagine them becoming something larger. That is a different kind of validation than technical proof alone but it matters.
What comes next
Strong communication, strategic framing and team quality can bring an early-stage company a long way. In deeptech they are not substitutes for technological progress. Our task is to keep moving from concept toward proof, deepen validation, reduce technical uncertainty and build the foundations for a material system that can compete in the real insulation market.
Participating was meaningful not because Ecolation had already reached maturity but because it had not. Being the earliest-stage venture in the group and still finishing near the top reinforced our conviction that strong early-stage deeptech is about technology, disciplined communication and a team capable of carrying the idea forward.